Suicidality Treatment Occurring in Paediatrics (STOP) Medication Suicidality Side Effects Scale in young people in two cohorts across Europe

Autor: David Coghill, Jatinder Singh, Federico Fiori, Paramala Santosh, Kate Lievesley, Diane Purper-Ouakil, Ulrike Schulze, Pieter J Hoekstra, Alessandro Zuddas, Ralf W Dittmann, Jan K Buitelaar, Celso Arango, Mohapradeep Mohan, Nathan Parnell, Regina Sala, Josefina Castro-Fornieles, Itziar Flamarique, Cloe Llorente

Publikováno v: BMJ Open, Vol 13, Iss 12 (2023)

Objectives As part of the ‘Suicidality: Treatment Occurring in Paediatrics (STOP)’ study, we developed and performed psychometric validation of an electronic-clinical-outcome-assessment (eCOA), which included a patient-reported-outcome (ePRO), an

Externí odkaz: https://doaj.org/article/6bbf0f92418c41adac07d69556ec1a87

Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial

Autor: Larissa Niemeyer, Konstantin Mechler, Ralf W. Dittmann, Tobias Banaschewski, Jan Buitelaar, Sarah Durston, Alexander Häge

Publikováno v: Contemporary Clinical Trials Communications, Vol 29, Iss , Pp 100982- (2022)

Background: Autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD) are mental disorders with a considerable overlap in terms of their defining symptoms. The glutamatergic agent memantine appears to be a promising candidate for the tre

Externí odkaz: https://doaj.org/article/9eb7c80286fa47c2afab5631a5780c1c

Editorial [Hot topic: Psychotropic Drugs in Child and Adolescent Psychiatry - a New Era on the Horizon (Executive Editors: Aribert Rothenberger, Manfred Gerlach and Ralf W. Dittmann)]

Autor: Rothenberger, Aribert, Gerlach, Manfred, W. Dittmann, Ralf

Publikováno v: Current Pharmaceutical Design; July 2010, Vol. 16 Issue: 22 p2395-2397, 3p

Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder

Autor: J.K. Buitelaar, G.H.H. van de Loo-Neus, L. Hennissen, C.U. Greven, P.J. Hoekstra, P. Nagy, A. Ramos-Quiroga, E. Rosenthal, S. Kabir, K.K.C. Man, Wong IC, D. Coghill, Alexander Häge, Tobias Banaschewski, Sarah K. Inglis, Sara Carucci, Marina Danckaerts, Ralf W. Dittmann, Bruno Falissard, Peter Garas, Chris Hollis, Kerstin Konrad, Hanna Kovshoff, Elizabeth Liddle, Suzanne McCarthy, Antje Neubert, Edmund J.S. Sonuga-Barke, Alessandro Zuddas

Publikováno v: European Neuropsychopharmacology, 64, 63-71. ELSEVIER SCIENCE BV
European neuropsychopharmacology : ENP 64, 63-71 (2022). doi:10.1016/j.euroneuro.2022.09.001
Scientia
European Neuropsychopharmacology, 64, pp. 63-71
European Neuropsychopharmacology, 64, 63-71

European neuropsychopharmacology : ENP 64, 63-71 (2022). doi:10.1016/j.euroneuro.2022.09.001
Published by Elsevier, Amsterdam

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78e5d3e534d9d13f480bc0b3b25af1c
https://hdl.handle.net/11370/f1ae0914-d241-4273-b46d-1550ce249da9

Nonstimulant Treatments for ADHD

Autor: Jeffrey H, Newcorn, Beth, Krone, Ralf W, Dittmann

Publikováno v: Child and Adolescent Psychiatric Clinics of North America. 31:417-435

Nonstimulants have an important role when response or tolerability to psychostimulants is poor, when certain comorbid disorders are present, or if patients prefer nonstimulants. Here, we discuss monotherapy and combined treatment of ADHD and review m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e3da48e37575f5984af285b1fe37403
https://doi.org/10.1016/j.chc.2022.03.005